Tri-Cities Tech Business Update
IsoRay receives FDA clearance
IsoRay, Inc., based in Richland, Wash., has received clearance from the Food and Drug Administration that will allow the company to expand its market for its ProxcelanTM Cesium-131 brachytherapy seeds. The Cesium-131 seeds are currently used in the treatment of prostate cancer. The FDA clearance will allow IsoRay to broaden the scope of treatments to include lung, head, and neck tumors as well as tumors in other organs.
Contact Dwight Babcock at 520-240-4840.
